Concepedia

Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older

Shoroq M. Altawalbeh, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman, Kenneth J. Smith

Applied Health Economics and Health Policy · 2023 · 10 citations · 26 references

DOIFull text

Open access

Concepts

References

26

United States Life Tables, 2019.

Elizabeth Arias, Jiaquan Xu · PubMed · 2022 · 498 citations

, , +17

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

Miwako Kobayashi, Jennifer L. Farrar, Ryan Gierke et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 344 citations · Full text

, , +17

Healthcare utilization and cost of pneumococcal disease in the United States

Susan S. Huang, Kristen Johnson, G. Thomas Ray et al. · Vaccine · 2011 · 305 citations · Full text

, , +15

Cost-Effectiveness of Vaccination against Invasive Pneumococcal Disease among People 50 through 64 Years of Age: Role of Comorbid Conditions and Race

Jane E. Sisk, William Whang, Jay C. Butler et al. · Annals of Internal Medicine · 2003 · 153 citations

, , +17

Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013

John M. McLaughlin, J.J. McGinnis, Litjen Tan et al. · The Journal of Primary Prevention · 2015 · 143 citations · Full text

, , +17